Today: 20 May 2026

Internet Access in Syria

Internet Access in Syria

Syria opened public internet access around 2000, years after establishing its first connection in 1997. By 2010–2011, about 4.5 million Syrians were online, but the government kept strict control over infrastructure and content. As of 2021, internet penetration reached 46–47%, still well below the regional average.
7 February 2025
··
Google’s Bard ‘Learnt Bengali’ Claim Has a Data Problem, Former Researcher Says

Google’s Bard ‘Learnt Bengali’ Claim Has a Data Problem, Former Researcher Says

A former Google AI researcher says Google’s claim that its Bard system “learned” Bengali on its own is misleading, citing company data showing Bengali was already in its training mix. The dispute follows a 2023 “60 Minutes” segment where Google executives called Bard’s language abilities a “black box.” Bard has since been rebranded as Gemini and integrated into Google’s core products.
6 July 2024
·
Zebra Medical Vision’s AI Reads Medical Images. Now Comes the Hospital Test

Zebra Medical Vision’s AI Reads Medical Images. Now Comes the Hospital Test

Nanox.AI, formerly Zebra Medical Vision, is now the imaging software unit of Nasdaq-listed Nanox, which acquired Zebra for $100 million in 2021. The company reported losses and financing risk in its 2026 filing but said it added Cedars-Sinai as a trial partner and accelerated U.S. deployment of its Nanox.ARC systems. NICE approved Nanox AI tools for NHS use during a three-year evidence period. FDA cleared its HealthFLD liver analysis software in 2024.
2 February 2024
·
AI Layoffs in 2023: The Real Number Was 4,247, and the Next Wave Is Harder to Count

AI Layoffs in 2023: The Real Number Was 4,247, and the Next Wave Is Harder to Count

U.S. employers cited artificial intelligence in 4,247 announced job cuts in 2023, according to Challenger, Gray & Christmas. By March 2026, AI was the top stated reason for U.S. job cuts that month, with 15,341 announced. The broader labor market showed 6.866 million job openings in March 2026, while layoffs remained at 1.2%, according to the Labor Department.
6 March 2023
···
1 … 1,955 1,956 1,957

Stock Market Today

  • Stock Market Continues Modest Pullback as Leading Growth Stocks Hold
    May 19, 2026, 7:45 PM EDT. The stock market extended its losing streak to three sessions on Tuesday, marking a modest and orderly pullback. Despite the slump, leading growth stocks demonstrated resilience, showing signs of underlying strength amid broader market pressure. Investors are watching carefully as the overall market digests recent gains, while specific oil and gas companies attract attention for potential opportunities. This cautious environment suggests investors are balancing profit-taking with selective buying in sectors showing robust performance.

Latest articles

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

20 May 2026
GCL Global Holdings shares jumped to $1.00 after hours Tuesday, up 132%, following news that ADATA Technology invested another $10 million in its 4Divinity unit. The stock had closed regular trading at $0.43, below Nasdaq’s $1 minimum. Recent filings still warn of listing and execution risks. GCL reported first-half revenue up 94% to $98.7 million but posted a net loss of $5.6 million.
James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Go toTop